Skip to content
HabitSeek
Back to results

Take a vitamin D supplement

Use a vitamin D supplement when it is indicated by dietary needs, a deficiency assessment, or local clinical guidance.

At a glance

  • Evidence: Routine vitamin D did not prevent fractures in generally healthy adults not selected for deficiency.Fracture prevention in generally healthy adults not selected for deficiency · Moderate certainty · Randomized intervention
  • What’s uncertain: Deficiency treatment and prevention guidance for specific populations are different questions.
  • First step: Review whether you have a clinical indication or population-specific reason for supplementation.
  • Before you try it: Avoid high doses or combining products without checking total vitamin D intake. All precautions
Read the full takeaway

Large randomized trials and meta-analyses do not show that routine vitamin D supplementation prevents fractures or reduces all-cause mortality in generally healthy adults who were not selected for deficiency. These results do not answer whether supplementation benefits people with diagnosed deficiency or specific clinical indications. Avoid high-dose self-treatment; the appropriate decision depends on individual risk and local guidance. Prevention guidance differs by population and should not be generalized into a single blood-level target. The 2024 Endocrine Society guideline separates generally healthy adults under 75 from older adults, pregnancy and high-risk prediabetes, and does not replace treatment of established deficiency. D3 raises total 25-hydroxyvitamin D more than D2 on average; this is a biomarker comparison, not proof of superior clinical prevention.

A bottle of vitamin D oil capsulesDiscussed by2 peopleView statements ↓
NutritionLong-term healthUnder 10 min · Easy · Low
Reviewed Oct 4, 2026
Save

Scientific evidence

What the research shows

Outcome assessments based on research, including its uncertainties and limitations.

Fracture prevention in generally healthy adults not selected for deficiency

Finding: Little/no effectCertainty: Moderatestudies found little or no effect

Evidence basis: randomised trials

Routine vitamin D supplementation did not reduce fractures in large trials of generally healthy adults.

Population: Generally healthy adults in randomized trials and meta-analyses; VITAL enrolled 25,871 US men aged 50 or older and women aged 55 or older, with median follow-up of 5.3 years.

Research details

Summary

A meta-analysis of 36 randomized trials involving 44,790 participants found no effect of vitamin D on total fractures (RR 1.00, 95% CI 0.93 to 1.07). In the VITAL fracture trial, vitamin D3 did not significantly affect total fractures in 25,871 generally healthy midlife and older adults (HR 0.98, 95% CI 0.89 to 1.08). Participants were not selected for vitamin D deficiency, low bone mass, or osteoporosis, so these results do not settle treatment for those conditions.

Why this certainty

Two large randomized evidence sources show a near-null fracture effect in broadly selected adults. Moderate certainty reflects the good trial base while keeping the conclusion limited to those populations.

Limitations

The trial population was not selected for deficiency or osteoporosis, and the findings should not be extended to treatment of diagnosed deficiency. Dose, baseline status, and co-interventions differed across the broader meta-analysis.

Effect estimate

VITAL total fracture HR 0.98 (95% CI 0.89 to 1.08); 36-trial meta-analysis RR 1.00 (95% CI 0.93 to 1.07).

Sources for this outcome:

All-cause mortality in randomized supplementation trials

Finding: Little/no effectCertainty: Moderatestudies found little or no effect

Evidence basis: randomised trials

Randomized trials show no clear all-cause mortality reduction from vitamin D supplementation.

Population: Adults enrolled in 50 randomized vitamin D supplementation trials, totaling 74,655 participants.

Research details

Summary

A meta-analysis of 50 randomized trials including 74,655 participants reported no significant effect of vitamin D on all-cause mortality (RR 0.98, 95% CI 0.95 to 1.02). In analyses by vitamin D type, neither vitamin D3 nor D2 significantly lowered all-cause mortality. The review reported a possible reduction in cancer death with D3, but that is a separate outcome and does not establish a general survival benefit.

Why this certainty

A large randomized synthesis gives a precise near-null estimate for all-cause mortality. Moderate certainty is appropriate for broadly tested adults, with less certainty for clinical subgroups not specifically studied.

Limitations

Trial populations, doses, duration, and baseline vitamin D status varied. The pooled all-cause estimate does not establish effects in people being treated for confirmed deficiency, and the cancer-mortality signal was a distinct secondary outcome. Population-specific prevention guidance is distinct from treatment of established deficiency; the cited guideline does not establish a universal preventive blood-level target.

Effect estimate

All-cause mortality RR 0.98 (95% CI 0.95 to 1.02).

Sources for this outcome:

Blood vitamin D status with D2 versus D3

Finding: Benefit supportedCertainty: Moderatestudies found a benefit from doing this

Evidence basis: randomised trials

D3 raises total 25-hydroxyvitamin D more than D2 on average.

Population: Participants in comparative D2/D3 supplementation studies with differing baseline vitamin D status and body mass index.

Research details

Summary

A synthesis of 20 comparative studies found a larger increase in total 25-hydroxyvitamin D with D3. In 12 daily-dose comparisons measured by LC-MS/MS, the D2-minus-D3 difference was -10.39 nmol/L (95% CI -14.62 to -6.16). Response varied with body mass index; clinical disease outcomes were not the comparison.

Why this certainty

Moderate for the blood-marker comparison, with heterogeneous response. It does not increase certainty for the existing clinical outcomes.

Limitations

Heterogeneity was substantial and body-mass information was incomplete. A laboratory concentration difference does not show that D3 prevents more fractures or extends life. Excluding studies at high risk of bias attenuated the daily-dose difference and its confidence interval included no difference; this further limits confidence in the exact size of the advantage.

Effect estimate

Daily D2 minus D3 change: -10.39 nmol/L (95% CI -14.62 to -6.16).

Sources for this outcome:

What people say

Who discusses this?

Public statements, with positions specific to each source and topic. These views do not determine the scientific evidence assessment.

What the research shows ↑

Practical steps and precautions

How to try it

  1. Separate routine prevention from known deficiency or another treatment indication. The Endocrine Society guideline advises against routine testing and supplementation above reference intake for generally healthy adults under 75.
  2. Age over 75, pregnancy and high-risk prediabetes have different prevention recommendations; discuss the applicable guidance rather than adopting one podcast target for everyone.
  3. Check whether the product contains D2 or D3 and review total intake from all products. D3 raises the measured blood marker more on average, but this does not establish superior clinical outcomes for everyone.
  4. If vitamin D is indicated, use an individualized plan; the guideline favours daily dosing over intermittent high doses in nonpregnant adults over 50. Do not self-prescribe large boluses.

Precautions

  • Excessive vitamin D intake can be harmful; do not use high doses without medical advice.
  • People with kidney disease, high blood calcium, granulomatous disease, or medicines that affect vitamin D metabolism should seek clinical guidance.

References

Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis

Bolland MJ, Grey A, Avenell A · The Lancet Diabetes & Endocrinology · 2018

Systematic review, meta-analysis, and trial sequential analysis of randomized trialsVerified from abstract
Open original source

Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults

LeBoff MS, Chou SH, Ratliff KA, et al. · The New England Journal of Medicine · 2022

Randomized placebo-controlled factorial trial with median 5.3-year follow-upVerified from abstract
Open original source

Association between vitamin D supplementation and mortality: systematic review and meta-analysis

Zhang Y, Fang F, Tang J, et al. · BMJ · 2019

Systematic review and meta-analysis of randomized controlled trialsVerified from abstract
Open original source

Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline.

Demay MB, Pittas AG, Bikle DD, Diab DL, Kiely ME, Lazaretti-Castro M, Lips P, Mitchell DM, Murad MH, Powers S, Rao SD, Scragg R, Tayek JA, Valent AM, Walsh JME, McCartney CR. · The Journal of clinical endocrinology and metabolism · 2024

GuidelineEndocrine Society GRADE clinical practice guideline; prevention recommendations exclude established treatment indicationsVerified from abstract
Open original source

Comparison of the Effect of Daily Vitamin D2 and Vitamin D3 Supplementation on Serum 25-Hydroxyvitamin D Concentration (Total 25(OH)D, 25(OH)D2, and 25(OH)D3) and Importance of Body Mass Index: A Systematic Review and Meta-Analysis.

van den Heuvel EG, Lips P, Schoonmade LJ, Lanham-New SA, van Schoor NM. · Advances in nutrition (Bethesda, Md.) · 2024

Systematic reviewSystematic review and meta-analysis of comparative vitamin D2 and D3 dosing studies. Results, sensitivity analyses and limitations checked in the NCBI full text (PMC10831883) on 2026-10-04. Excluding high-risk studies attenuated the LC-MS/MS daily-dose comparison to -7.27 nmol/L (95% CI -14.67 to 0.14); BMI data were incomplete, and the outcome is a blood marker rather than a clinical benefit.Verified from full text
Open original source

Community

Discussion

Have you tried this? What helped or made it difficult?

Reader experiences are separate from the scientific evidence. Explore all discussions

No discussions yet.

Be the first to ask a question or share your experience.

Sign in to vote or join the discussion.

Related habits

Explore other habits in a shared category. Each has its own evidence and precautions.

Editorial history and review method

Revision 6 · Approved for publication · HabitSeek site owner (publication approval); Codex discovery audit

Prepared and checked with AI. Publication approval does not imply independent expert review. Request a correction.

Adds fracture and all-cause mortality assessments based on large randomized syntheses. Recheck exact bibliographic metadata and preserve the distinction between routine use in generally healthy adults and supplementation for diagnosed deficiency. Europe PMC lookup returned empty results in this runtime, so source facts were checked against retrieved PubMed or journal records; recheck the source metadata and access status before approval. October 3 video follow-up: Added population-specific prevention guidance and a separate D2/D3 status comparison. Verify correction notices accompanying the 2024 guideline and preserve its distinction from established treatment indications. No universal target or podcast dose was adopted. Publication release 2026-10-04: site owner authorized a bounded AI audit and release of this exact revision. See docs/release-audit-2026-10-04.md for source-check findings and limits. No independent health-professional or peer review is claimed. Category migration 2026-10-04: removed the separate goals field; categories: Nutrition, Long-term health → Nutrition, Long-term health. Research assessments, sources, guidance, precautions, and evidence review dates are unchanged. This revision awaits publication approval; no new evidence review is claimed. Publication approval 2026-10-04: site owner explicitly accepted all current category-migration revisions for deployment and requested that remaining limitations be retained in docs/content-review-backlog.md. Approval applies to this exact content revision. No new evidence review, independent expert review, or clinical validation is claimed; existing precautions and disclosures remain in effect. Discovery audit 2026-10-10: added familiar search aliases. Outcome assessments, evidence sources, practical guidance, precautions and evidence-review date are unchanged. Formulation aliases identify the topic covered, not an endorsement or a new effectiveness claim. This exact revision awaits publication approval. Publication approval 2026-10-10: site owner answered 'Approve and publish' to the question explicitly covering these eight naming/search revisions and deployment to habitseek.com. Approval applies to this exact revision. Evidence assessments, guidance, precautions and scientific review dates were unchanged by the discovery audit. This is publication approval, not independent expert or clinical validation. The 15 later supplement drafts are outside this approval.